Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px
Document › Details

Eurofins Scientific. (12/21/15). "Press Release: Eurofins Reinforces Market Leadership in Environment Testing in Europe with the Acquisition of NUA and Water & Waste Laboratories in Austria, and Radonlab in Norway".

Region Region Austria
Organisation Organisation Eurofins Scientific SE (EUFI.PA)
  Group Eurofins (Group)
Products Product environmental analysis
  Product 2 analytical services
Index term Index term NUA GmbH–Eurofins: investment, 201503 acquisition by Eurofins
Person Person Martin, Gilles G. (Eurofins 200701 CEO + founder)
     


Eurofins Scientific (EUFI.PA), the world leader in environment testing services, announces the acquisition of NUA-Umweltanalytik GmbH ("NUA") and Water & Waste Gesellschaft für Umweltschutz und chemische Laboratorien GmbH ("Water & Waste"), two of the market leaders in environmental testing in Austria, and of Radonlab, the premier radon testing laboratory in Norway.

NUA is one of the leading private laboratories for environmental analyses in the Austrian market, and is renowned for water testing. Founded in 1974, NUA's 45 staff provides both chemistry and microbiology analyses of water, soil and air to a large number of both public and private clients, with a regional focus in Lower Austria.

Waste & Water leads the market in soil and waste analysis, and is a reference laboratory for water and site contamination testing, as well as geotechnical analysis. The company employs 65 staff serving most of the local municipalities in Austria, as well as the domestic building and construction industry. Waste & Water is also the testing laboratory for 4 out of the 5 high contamination waste sites in the country.

These 2 acquisitions secure the Group's market leadership and ensure that Eurofins has the most comprehensive service offering in Austria. In addition, the complementarity of the services of the two laboratories should result in significant cross-selling opportunities, as well as a strong platform on which to expand the Group's footprint across the country.

In Norway, where Eurofins is already the market leader in environment testing, the Group acquired the country's premier laboratory for radon testing. With radon exposure identified by the World Health Organization as the second most important cause of lung cancer[1], and with Norway having the highest radon concentrations in indoor air, the country has one of the most stringent regulations on radon testing. Radonlab's expertise in this field is reflected in its strong relationships with local municipalities as the reference laboratory for radon testing. This acquisition provides Eurofins the competence in this increasingly important niche market, which could be rolled-out more widely to complement the Group's existing portfolio of environment testing services.

Comment from Dr. Gilles Martin, Eurofins CEO: "The acquisition of NUA and Water & Waste in Austria, and Radonlab in Norway reflects our commitment to expand both our geographical and operating footprint, as well as reinforce our market leadership in environment testing. These acquisitions are a further demonstration of Eurofins' commitment to build the best and widest-reaching analytical testing network in the market."


For more information, please visit www.eurofins.com or contact:

Eurofins Investor Relations
Phone: +32-2-766 1620
E-mail: ir@eurofins.com


Notes for the editor:

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food, environment and pharmaceutical products testing. It is also one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

With 20,000 staff in around 200 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).


[1] http://www.who.int/mediacentre/factsheets/fs291/en/


Important disclaimer: This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.

   
Record changed: 2016-05-01

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Eurofins (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px